The expanding number of new type 2 diabetes agents and how to effectively use them can be challenging. This one day module provides updates on the latest injectable therapies, both GLP1s and insulin. Practical workshop and case study discussions as well as providing updated knowledge and skills to enhance patient glycaemic management.
The topics covered include:
The newly updated (Dec 2015 with added update 2017) NICE guidance
Latest glycaemic treatment options
The latest evidence on prescribing the newer agents including SGLT2s